Pyridazinodiazepines as a high-affinity, P2-P3 peptidomimetic class of interleukin-1 beta-converting enzyme inhibitor.

R E Dolle; C V Prasad; C P Prouty; J M Salvino; M M Awad; S J Schmidt; D Hoyer; T M Ross; T L Graybill; G J Speier

doi:10.1021/jm9701637

Pyridazinodiazepines as a high-affinity, P2-P3 peptidomimetic class of interleukin-1 beta-converting enzyme inhibitor.

NobleID: NI7P80W61R88S90
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/2CC35C20

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2CC35C20.svg?ark=w1%2F20260515%2F2CC35C20&value=id)](https://nobleid.org/work/w1/20260515/2CC35C20)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Pyridazinodiazepines as a high-affinity, P2-P3 peptidomimetic class of interleukin-1 beta-converting enzyme inhibitor.

NobleID: NI7P80W61R88S90
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/2CC35C20

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2CC35C20.svg?ark=w1%2F20260515%2F2CC35C20&value=id)](https://nobleid.org/work/w1/20260515/2CC35C20)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work